
Company valuation, historical trends, and peer comparisons.
According to NanoRepro AG’s latest financial reports and current stock price. The company's current Enterprise Value is 14.07M. This represents a change of 97.42% compared to the average of 7.13M of the last 4 quarters.
The mean historical Enterprise Value of NanoRepro AG over the last ten years is 15.61M. The current 14.07M Enterprise Value has changed -9.89% with respect to the historical average. Over the past ten years (40 quarters), NNGRF's Enterprise Value was at its highest in in the December 2021 quarter at 68.78M. The Enterprise Value was at its lowest in in the December 2022 quarter at -2742646.67.
Average
15.61M
Median
8.67M
Minimum
-2742646.67
Maximum
68.78M
Discovering the peaks and valleys of NanoRepro AG Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 547.35%
Maximum Annual Enterprise Value = 68.78M
Minimum Annual Increase = -421.96%
Minimum Annual Enterprise Value = -2742646.67
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 11.28M | 31.81% |
| 2024 | 8.56M | -3.05% |
| 2023 | 8.83M | -421.96% |
| 2022 | -2742646.67 | -103.99% |
| 2021 | 68.78M | 95.00% |
| 2020 | 35.27M | 547.35% |
| 2019 | 5.45M | -22.74% |
| 2018 | 7.05M | -19.64% |
| 2017 | 8.78M | 81.40% |
| 2016 | 4.84M | 23.58% |
The current Enterprise Value of NanoRepro AG (NNGRF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.56M
5-year avg
18.94M
10-year avg
15.61M
NanoRepro AG’s Enterprise Value is less than ACS Global, Inc. (0), less than Broncus Holding Corporation (17.36M), less than EKF Diagnostics Holdings plc (86.07M), less than Adocia S.A. (62.50M), less than Diaceutics PLC (165.77M), less than Recce Pharmaceuticals Ltd (116.30M), less than Volpara Health Technologies Limited (284.13M), less than Creso Pharma Limited (28.39M), less than AnGes, Inc. (11.21B), greater than Cell MedX Corp. (6.08M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 0 | $171.27M | |
| 17.36M | $161.66M | |
| 86.07M | $140.76M | |
| 62.50M | $170.44M | |
| 165.77M | $195.62M | |
| 116.30M | $67.27M | |
| 284.13M | $188.24M | |
| 28.39M | $131.72M | |
| 11.21B | $143.66M | |
| 6.08M | $126.33M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoRepro AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoRepro AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NanoRepro AG's Enterprise Value?
What is the highest Enterprise Value for NanoRepro AG (NNGRF)?
What is the 3-year average Enterprise Value for NanoRepro AG (NNGRF)?
What is the 5-year average Enterprise Value for NanoRepro AG (NNGRF)?
How does the current Enterprise Value for NanoRepro AG (NNGRF) compare to its historical average?